丽珠医药11月4日斥资599.98万元回购16.47万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, intending to repurchase 164,700 A-shares at a total cost of 5.9998 million yuan [1] Group 1 - The company plans to execute the buyback on November 4, 2025 [1] - The total expenditure for the buyback is approximately 5.9998 million yuan [1] - The number of shares to be repurchased is 164,700 [1]